Broad Antitumor Activity in Breast Cancer Xenografts by Motesanib, a Highly Selective, Oral Inhibitor of Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors
2008 ◽
Vol 15
(1)
◽
pp. 110-118
◽
2001 ◽
Vol 92
(12)
◽
pp. 1342-1351
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. e14010-e14010
2007 ◽
Vol 13
(3)
◽
pp. 1061-1067
◽
2009 ◽
Vol 8
(7)
◽
pp. 1761-1771
◽
2002 ◽
Vol 29
(3 Suppl 11)
◽
pp. 29-37
◽